Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.7.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue:    
Milestones $ 3,000,000 $ 0
Total revenues 3,000,000 0
Operating costs and expenses:    
Research and development (43,737,814) (3,434,016)
General and administrative (6,692,786) (6,388,000)
Loss from operations (47,430,600) (9,822,016)
Other income (expense):    
Change in fair value of derviative liability 2,125,113 (2,125,117)
Loss on issuance of hybrid debt instruments (1,690,784) (59,612)
Loss on conversion of debt (6,394,921) 0
Other expense (85,374) (235,421)
Interest income 32 1,694
Interest expense (729,572) (266,999)
Total other expense (6,775,506) (2,685,455)
Net loss (54,206,106) (12,507,471)
Accretion of beneficial conversion feature on convertible preferred stock (4,035,260) 0
Net loss applicable to common stockholders (58,241,366) (12,507,471)
Other comprehensive income (loss)    
Other comprehensive loss from foreign currency translation adjustment 0 (321,942)
Total comprehensive loss $ (54,206,106) $ (12,829,413)
Basic and diluted loss per share applicable to common stockholders $ (7.84) $ (2.96)
Weighted-average shares of common stock outstanding, basic and diluted 7,430,574 4,223,905